Our previous study [66] has shown how NF-κB is constitutively activated in an HCC cell line, HA22T/VGH, and its inhibition is helpful in antagonizing IAPs and other target genes implicated in the biology of this tumor. The gene discussed is NFKB1; the disease is hepatocellular carcinoma.